ARNAX is an ideal adjuvant for COVID-19 vaccines to enhance antigen-specific CD4(+) and CD8(+) T-cell responses and neutralizing antibody induction
ARNAX是一种理想的COVID-19疫苗佐剂，可增强抗原特异性CD4(+)和CD8(+) T细胞反应以及中和抗体的诱导。
期刊:Journal of Virology
影响因子:3.8
doi:10.1128/jvi.02290-24
Kawakita, Tomomi; Sekiya, Toshiki; Kameda, Yayoi; Nomura, Naoki; Ohno, Marumi; Handabile, Chimuka; Yamaya, Akari; Fukuhara, Hideo; Anraku, Yuki; Kita, Shunsuke; Toba, Shinsuke; Tsukamoto, Hirotake; Sawa, Tomohiro; Oshiumi, Hiroyuki; Itoh, Yasushi; Maenaka, Katsumi; Sato, Akihiko; Sawa, Hirofumi; Suzuki, Yasuhiko; Brown, Lorena E; Jackson, David C; Kida, Hiroshi; Matsumoto, Misako; Seya, Tsukasa; Shingai, Masashi
